First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis.

Liting WangYe PengShuxia QinXiaomin WanXiaohui ZengSini LiQiao LiuChongqing Tan

Published in: PloS one (2023)

For oral multikinase inhibitors, the order of possible treatment options is sunitinib > lenvatinib > sorafenib plus erlotinib > linifanib > brivanib > donafenib. For ICIs, the order of possible treatment options is sintilimab plus IBI305 > atezolizumab plus bevacizumab.

Keyphrases

renal cell carcinoma
epidermal growth factor receptor
advanced non small cell lung cancer
locally advanced
metastatic colorectal cancer
squamous cell carcinoma
rectal cancer